A Hereditary Breast and Ovarian Cancer (HBOC) Patient with Metastatic Breast Cancer Lacking BRCA Loss of Heterozygosity (LOH) but Responding to PARP Inhibitor Therapy
molecular basis for diagnosing an individual with Hereditary Breast and Ovarian Cancer (HBOC) syndrome, the most common inherited breast cancer-predisposing syndrome. The gatekeeper or transforming event almost always…

